Vanda Pharmaceuticals Inc.
DE ˙ DB ˙ US9216591084
5,26 € ↑0,09 (1,74%)
2026-06-05
DEL PRIS
SecurityDE:VM4 / Vanda Pharmaceuticals Inc.
InstitutionPanagora Asset Management Inc
Latest Disclosed Ownership113,289 shares
Latest Disclosed Value $ 782,827
Panagora Asset Management Inc reports 4.79% decrease in ownership of VM4 / Vanda Pharmaceuticals Inc.

On May 14, 2026 - Panagora Asset Management Inc filed a 13F-HR form disclosing ownership of 113,289 shares of Vanda Pharmaceuticals Inc. (DE:VM4) valued at $651,412 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 118,987 shares of Vanda Pharmaceuticals Inc.. This represents a change in shares of -4.79% during the quarter. The current value of the position is $595,900 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F VANDA PHARMACEUTICALS COM 921659108 113,289 -5,698 -4.79 783 -25.45 0.0029
2026-02-13 2025-12-31 13F VANDA PHARMACEUTICALS COM 921659108 118,987 3,928 3.41 1,049 82.75 0.0037
2025-11-13 2025-09-30 13F VANDA PHARMACEUTICALS COM 921659108 115,059 115,059 574 0.0023
2025-02-13 2024-12-31 13F VANDA PHARMACEUTICALS COM 921659108 0 -46,781 -100.00 0 -100.00
2024-11-13 2024-09-30 13F VANDA PHARMACEUTICALS COM 921659108 46,781 -13,653 -22.59 219 -35.78 0.0010
2024-07-29 2024-06-30 13F VANDA PHARMACEUTICALS COM 921659108 60,434 2,509 4.33 341 43.28 0.0017
2024-05-07 2024-03-31 13F VANDA PHARMACEUTICALS COM 921659108 57,925 234 0.41 238 -2.06 0.0012
2024-02-08 2023-12-31 13F VANDA PHARMACEUTICALS COM 921659108 57,691 454 0.79 243 -1.62 0.0014
2023-10-31 2023-09-30 13F VANDA PHARMACEUTICALS COM 921659108 57,237 136 0.24 247 -34.31 0.0015
2023-08-11 2023-06-30 13F VANDA PHARMACEUTICALS COM 921659108 57,101 -127,044 -68.99 376 -69.92 0.0022
2023-05-12 2023-03-31 13F VANDA PHARMACEUTICALS COM 921659108 184,145 -109,298 -37.25 1,250 -42.34 0.0079
2023-02-13 2022-12-31 13F VANDA PHARMACEUTICALS COM 921659108 293,443 97,683 49.90 2,169 12.10 0.0142
2022-11-14 2022-09-30 13F VANDA PHARMACEUTICALS COM 921659108 195,760 77,880 66.07 1,934 50.51 0.0134
2022-08-15 2022-06-30 13F VANDA PHARMACEUTICALS COM 921659108 117,880 71,349 153.34 1,285 144.30 0.0084
2022-05-12 2022-03-31 13F VANDA PHARMACEUTICALS COM 921659108 46,531 9,642 26.14 526 -9.15 0.0029
2022-02-10 2021-12-31 13F VANDA PHARMACEUTICALS COM 921659108 36,889 0 0.00 579 -8.39 0.0031
2021-11-10 2021-09-30 13F VANDA PHARMACEUTICALS COM 921659108 36,889 0 0.00 632 -20.30 0.0034
2021-08-11 2021-06-30 13F VANDA PHARMACEUTICALS COM 921659108 36,889 34,130 1,237.04 793 1,834.15 0.0042
2021-05-12 2021-03-31 13F VANDA PHARMACEUTICALS COMMON 921659108 2,759 -68,006 -96.10 41 -95.59 0.0002
2021-02-10 2020-12-31 13F VANDA PHARMACEUTICALS COMMON 921659108 70,765 33 0.05 930 36.16 0.0055
2020-11-13 2020-09-30 13F VANDA PHARMACEUTICALS COMMON 921659108 70,732 2,726 4.01 683 -12.21 0.0043
2020-08-12 2020-06-30 13F VANDA PHARMACEUTICALS COMMON 921659108 68,006 -91,664 -57.41 778 -52.96 0.0050
2020-05-14 2020-03-31 13F VANDA PHARMACEUTICALS COMMON 921659108 159,670 -404,125 -71.68 1,654 -82.12 0.0117
2020-02-12 2019-12-31 13F VANDA PHARMACEUTICALS COMMON 921659108 563,795 122,616 27.79 9,252 57.91 0.0420
2019-11-12 2019-09-30 13F VANDA PHARMACEUTICALS COMMON 921659108 441,179 -28,943 -6.16 5,859 -11.55 0.0270
2019-08-09 2019-06-30 13F VANDA PHARMACEUTICALS COMMON 921659108 470,122 52,392 12.54 6,624 -13.82 0.0296
2019-05-15 2019-03-31 13F VANDA PHARMACEUTICALS COMMON 921659108 417,730 -1,729 -0.41 7,686 -29.87 0.0342
2019-02-14 2018-12-31 13F VANDA PHARMACEUTICALS COMMON 921659108 419,459 -10,634 -2.47 10,960 11.03 0.0510
2018-11-13 2018-09-30 13F VANDA PHARMACEUTICALS COMMON 921659108 430,093 103,955 31.87 9,871 58.88 0.0371
2018-08-14 2018-06-30 13F VANDA PHARMACEUTICALS COMMON 921659108 326,138 49,122 17.73 6,213 33.10 0.0246
2018-05-15 2018-03-31 13F VANDA PHARMACEUTICALS COMMON 921659108 277,016 8,482 3.16 4,668 14.36 0.0184
2018-02-14 2017-12-31 13F VANDA PHARMACEUTICALS COMMON 921659108 268,534 38,857 16.92 4,082 -0.71 0.0153
2017-11-14 2017-09-30 13F VANDA PHARMACEUTICALS COMMON 921659108 229,677 136,567 146.67 4,111 170.82 0.0163
2017-08-14 2017-06-30 13F VANDA PHARMACEUTICALS COMMON 921659108 93,110 -14,014 -13.08 1,518 1.20 0.0061
2017-05-15 2017-03-31 13F VANDA PHARMACEUTICALS COMMON 921659108 107,124 36,894 52.53 1,500 33.93 0.0062
2017-02-14 2016-12-31 13F VANDA PHARMACEUTICALS COMMON 921659108 70,230 34,718 97.76 1,120 89.51 0.0051
2016-11-14 2016-09-30 13F VANDA PHARMACEUTICALS COMMON 921659108 35,512 35,512 0.00 591 0.0028
2016-08-15 2016-06-30 13F VANDA PHARMACEUTICALS COMMON 921659108 0 -9,007 -100.00 0 -100.00
2016-05-16 2016-03-31 13F VANDA PHARMACEUTICALS COMMON 921659108 9,007 3,850 74.66 75 56.25 0.0004
2016-02-12 2015-12-31 13F VANDA PHARMACEUTICALS COMMON 921659108 5,157 1,592 44.66 48 20.00 0.0002
2015-11-13 2015-09-30 13F VANDA PHARMACEUTICALS COMMON 921659108 3,565 -12,445 -77.73 40 -80.30 0.0002
2015-08-14 2015-06-30 13F VANDA PHARMACEUTICALS COMMON 921659108 16,010 -5,074 -24.07 203 3.57 0.0010
2015-05-15 2015-03-31 13F VANDA PHARMACEUTICALS COMMON 921659108 21,084 21,084 0.00 196 0.0010
2014-08-14 2014-06-30 13F VANDA PHARMACEUTICALS COMMON 921659108 0 -2,864 -100.00 0 -100.00
2014-05-15 2014-03-31 13F VANDA PHARMACEUTICALS COMMON 921659108 2,864 2,864 47 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.